Furthermore, no significant correlation was observed between the BCR–ABL1 transcript and SKP2 gene expression levels in the CML patients in the present study, suggesting that the SKP2 gene might be associated with BCR–ABL1-independent resistance to IM. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.